DSM to Double Capacity for Engineering Plastics in China

Royal DSM N.V. has announced the opening of its new compounding site for engineering plastics at Jiangyin in the Jiangsu province of China on April 26, 2006. This project will double the total capacity for the product lines Stanyl® PA46, Akulon® PA6 and Arnite® PBT. These materials are used in manufacturing key molded components for the automotive, electrical and electronics, consumer and industrial segments.

DSM has continued its solid growth in China during the last decade by offering innovative, value-added application solutions to its customers. The new manufacturing facility illustrates DSM’s long term commitment to the Chinese market. It provides the Chinese customers with local access to DSM’s global technology, and will further improve customer service levels.  

The new manufacturing facility uses leading edge compounding technology and is fully equipped with best-in-class safety, health and environment compliance systems. This new facility will meet the growing local demand of the Chinese market and serve as a prime sourcing base for the Asia Pacific region. The facility design allows for additional capacity expansion to accommodate further growth in demand in the future.

We have managed to develop and grow our business in China very fast over recent years. This project is an important new step in the context of DSM’s strategy Vision 2010 – Building on Strengths. It serves two key strategic targets: market-driven growth and innovation in the Performance Materials cluster and expanding our presence in the emerging China market .” comments Nico Gerardu, member of the Managing Board of DSM N.V.

The project includes the expansion of DSM Engineering Plastics’ Regional Development Service Center. This will further enhance DSM’s capability to offer technical and design support to its customers, specifically in China and within the region.

http://www.dsm.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.